Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

UK prepares to 'flex' vaccination program to tackle Indian Covid-19 variant

Fri, 14th May 2021 11:16

(Sharecast News) - UK vaccines minister Nadhim Zahawi said on Friday that the government was gearing up to "flex" its inoculation program in order to tackle the new coronavirus variant first detected in India.
Local lockdowns in areas where that variant was most present were another possibility, although for now the next phase for easing restrictions in England, which was due to start from 17 May, was still set to go ahead, he added.

Speaking to the BBC, the minister said that there would be a surge in vaccinations and testing in areas where that specific variant was spreading.

At the same time, the Department of Health and Social Care announced on Thursday that a new "surge rapid response" team of 100 staff would be deployed to Bolton, where the B1.617.2 variant was already rapidly spreading.

"While there is no firm evidence yet to show this variant has any greater impact on severity of disease or evades the vaccine, the speed of growth is concerning and the government is considering additional action if deemed necessary, including how to best utilize the vaccine roll-out to best protect the most vulnerable in the context of the current epidemiology," the Department said in the statement.



Currently, almost 70% of UK adults, or about 36.0m people, had been administered at least one shot of the Covid-19 vaccines.

Of those, 19.0m had already received their second dose, with the rest originally expected to follow up to 12 weeks after their first shot.

Vaccines were currently available to anyone over the age of 38, but the government also said that they could be made available to younger people living in multi-generational households.

From 17 May, people in England and Wales would again be allowed to meet inside homes, pubs and restaurants, cinemas would reopen and overseas holiday travel would restart.

Related Shares

More News
Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemi...

Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was ...

7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.